首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6674篇
  免费   93篇
  国内免费   6篇
耳鼻咽喉   265篇
儿科学   245篇
妇产科学   359篇
基础医学   282篇
口腔科学   112篇
临床医学   331篇
内科学   1353篇
皮肤病学   307篇
神经病学   289篇
特种医学   505篇
外科学   1939篇
综合类   20篇
预防医学   191篇
眼科学   253篇
药学   21篇
中国医学   1篇
肿瘤学   300篇
  2023年   10篇
  2021年   5篇
  2020年   7篇
  2019年   6篇
  2018年   24篇
  2017年   18篇
  2016年   27篇
  2015年   503篇
  2014年   566篇
  2013年   559篇
  2012年   565篇
  2011年   516篇
  2010年   586篇
  2009年   549篇
  2008年   571篇
  2007年   490篇
  2006年   460篇
  2005年   395篇
  2004年   265篇
  2003年   50篇
  2002年   9篇
  2001年   13篇
  2000年   12篇
  1999年   29篇
  1998年   24篇
  1997年   46篇
  1996年   39篇
  1995年   26篇
  1994年   25篇
  1993年   28篇
  1992年   17篇
  1991年   21篇
  1990年   16篇
  1989年   20篇
  1988年   20篇
  1987年   15篇
  1986年   14篇
  1985年   8篇
  1984年   12篇
  1983年   28篇
  1982年   27篇
  1981年   27篇
  1980年   22篇
  1979年   21篇
  1978年   5篇
  1977年   10篇
  1976年   11篇
  1975年   9篇
  1974年   6篇
  1973年   7篇
排序方式: 共有6773条查询结果,搜索用时 28 毫秒
161.
162.
The greatest problem for healthy individuals and those with pre-existing diseases at middle and high altitudes is oxygen deficiency through hypobaric hypoxia. Hypoxia can lead to typical altitude sickness, acute mountain sickness, altitude cerebral edema and altitude pulmonary edema. The occurrence of this disease is avoidable by adequate acclimatization. If it occurs despite acclimatization improvement can be achieved by rapid descent, oxygen inhalation or medicinal therapy. Patients with pre-existing pulmonary diseases are endangered even at low altitudes and this also holds true for air flights because cabin pressure heights up to 2,438 m can be reached. Only patients with good pulmonary function and sufficient oxygenation tolerate these conditions without problems. Especially endangered are patients with limited hyperventilation or diffusion capacity and high pulmonary pressure. This article presents pre-flight possibilities to recognize those patients who would possibly profit from additional oxygen inhalation during the flight using lung function, blood gases and oxygen saturation.  相似文献   
163.
164.
165.
166.
167.
168.
Rigid algorithms providing identical glycemic treatment goals and intervention thresholds for all patients with both type 1 and type 2 diabetes are obsolete. In patients with type 1 diabetes, intensive insulin therapy using short-acting and long-lasting basal analog insulins are superior compared to normal or intermediate human insulins with respect to the risks of hypoglycemia, quality of glycemic control and quality of life. If correctly indicated, insulin pump therapy with continuous subcutaneous insulin infusion (CSII) offers superior glycemic control compared to intensive insulin treatment. In patients with type 2 diabetes, individualized and patient-centered treatment strategies tailored to the respective phase of the chronic progressive disease are warranted. The best point in time to start insulin therapy depends on the extent of hyperglycemia and comorbidities taking into account the state of the disease, safety aspects (e.g. hypoglycemia, adverse effects and body weight gain) and the preferences of the patient. In patients with severe (skeletal muscle) insulin resistance and poor glycemic control, very high doses of insulin with the aim to override insulin resistance do not seem prudent as muscle insulin resistance also serves as a protective mechanism preventing further nutrient drainage into the muscle tissue. Instead, strategies to improve insulin sensitivity by reducing nutrient load, such as calorie restriction, increase of physical activity as well as administration of metformin, incretin-based treatment and sodium-glucose-linked transporter-2 (SGLT-2) inhibitors should form the basis for therapy in such patients. Transient, short-term treatment with insulin, often started at manifestation of the disease -if plasma glucose values are high, quickly removes the negative effects of glucotoxicity and may offer beneficial metabolic long-term effects.  相似文献   
169.
170.
In recent years sales of non-alcoholic beer have constantly increased. In Germany, so-called non-alcoholic beer may still have an ethanol content of up to 0.5% (by volume). This marginal amount of ethanol might have negative implications for certain groups of persons such as novice drivers. So far no reliable data regarding the blood ethanol concentration after consumption of non-alcoholic beer have been published. Therefore, a drinking experiment was performed as follows: after 5 days of abstinence from ethanol 78 test persons were asked to drink 1.5?l of non-alcoholic beer (ethanol content 0.41–0.42%) within 1?h. Blood samples were taken on a regular basis and analyzed for ethanol by headspace gas chromatography-flame ionization detection (HS-GC-FID). A total of 67 data sets could be interpreted and in 20 test persons ethanol was detected in blood with a limit of detection (LOD) of 0.0005?g/l. The maximum blood ethanol concentration was 0.0056‰. The results of the study suggest that even after consumption of unrealistically high amounts of non-alcoholic beer negative forensic implications are not to be expected.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号